Company Profiles

driven by the PitchBook Platform

Abgentis

Description

Provider of next generation of IV/oral antibacterials designed for antibacterial re-engineering. The company's next generation of IV/oral antibacterials offer treatment for acute, chronic, life-threatening and drug-resistant infections by increasing the immune system of body using microbiology, pharmacology and efficacy of antibacterial DNA super coiling inhibitors, providing consumers with treatments for life-threatening bacterial infection.

2012

Founded

PRIVATE

Status

Early Stage VC

Latest Deal Type

$333k

Latest Deal Amount

$333k

Total Amount Raised

2

Investors

Description

Provider of next generation of IV/oral antibacterials designed for antibacterial re-engineering. The company's next generation of IV/oral antibacterials offer treatment for acute, chronic, life-threatening and drug-resistant infections by increasing the immune system of body using microbiology, pharmacology and efficacy of antibacterial DNA super coiling inhibitors, providing consumers with treatments for life-threatening bacterial infection.

Website:

www.abgentis.com

Ownership Status

Privately Held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Biotechnology

Other Industries

Other Healthcare
Drug Discovery

Primary Office

Birmingham Research Park Vincent Drive Edgbaston B15 2SQEngland +44 (0)12 3553 2481
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore Abgentis's full profile, request a free trial.

    Abgentis Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    Abgentis Cap Table

    Stock# of Shares
    Authorized
    Par ValueDividend Rate (%)Original
    Issue Price
    LiquidationLiquidation
    Pref. Multiple
    Conversion
    Price
    % Owned

    Abgentis Investors (2)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    MidvenVenture CapitalMinority000 0000000 0000
    Oxford TechnologyVenture CapitalMinority000 0000000 0000
    Midven Venture Capital
    Oxford Technology Venture Capital

    Abgentis Executive Team (1)

    NameTitleBoard
    Seat
    Contact
    Info
    Lloyd CzaplewskiBoard Member & Founder
    Lloyd Czaplewski Board Member & Founder

    Abgentis Board Members (2)

    NameRepresentingRoleSinceContact
    Info
    Andrew MuirSelfBoard Member000 0000
    Lloyd CzaplewskiAbgentisBoard Member & Founder000 0000
    Andrew Muir Board Member Self
    Lloyd Czaplewski Board Member & Founder Abgentis
    Request full access to PitchBook